Detalhe da pesquisa
1.
Clinical utility of a cytomegalovirus-specific T cell assay in assessing the risk of post-prophylaxis cytomegalovirus infection and post-treatment relapse.
Clin Transplant
; 37(12): e15143, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805968
2.
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease.
Transpl Infect Dis
; 23(4): e13682, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216086
3.
Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature.
Open Forum Infect Dis
; 9(12): ofac643, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570971
4.
Infectious complications in patients on treatment with Ruxolitinib: case report and review of the literature.
Infect Dis (Lond)
; 50(5): 381-387, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29251529